Selective serotonin reuptake inhibitors and Alzheimer’s disease

Selective serotonin reuptake inhibitors and Alzheimer’s disease

Given the failure to develop disease-modifying therapies for Alzheimer’s disease (AD), strategies aiming at preventing or delaying the onset of the disease are being prioritized. While the debate regarding whether depression is an etiological risk factor or a prodrome of AD rages on, a key determini...

Full description

Bibliographic Details
Main Authors: Bernadette Mdawar, Elias Ghossoub, Rita Khoury
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Neural Regeneration Research
Subjects:
Alzheimer’s disease; amyloidogenesis; animal models; antidepressant; depression; onset delay; prevention; selective serotonin reuptake inhibitor; SSRI
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=1;spage=41;epage=46;aulast=Mdawar

Internet

http://www.nrronline.org/article.asp?issn=1673-5374;year=2020;volume=15;issue=1;spage=41;epage=46;aulast=Mdawar

Similar Items